KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-cash Items (2016 - 2019)

Supernus Pharmaceuticals (SUPN) has disclosed Non-cash Items for 9 consecutive years, with $2.6 million as the latest value for Q1 2019.

  • Quarterly Non-cash Items rose 7.07% to $2.6 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Mar 2019, up 7.07% year-over-year, with the annual reading at $1.9 million for FY2018, 3.22% down from the prior year.
  • Non-cash Items for Q1 2019 was $2.6 million at Supernus Pharmaceuticals, up from $1.9 million in the prior quarter.
  • The five-year high for Non-cash Items was $108.5 million in Q4 2017, with the low at $856008.0 in Q2 2015.
  • Average Non-cash Items over 5 years is $11.8 million, with a median of $1.9 million recorded in 2018.
  • The sharpest move saw Non-cash Items skyrocketed 530.0% in 2015, then crashed 98.26% in 2018.
  • Over 5 years, Non-cash Items stood at $12.6 million in 2015, then skyrocketed by 333.91% to $54.7 million in 2016, then soared by 98.49% to $108.5 million in 2017, then plummeted by 98.26% to $1.9 million in 2018, then soared by 37.87% to $2.6 million in 2019.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $2.6 million, $1.9 million, and $1.9 million for Q1 2019, Q4 2018, and Q3 2018 respectively.